CompletedN/ADMT

Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study

Sponsored by University of Utah

NCT ID
NCT00722943
Target Enrollment
46 participants
Start Date
2008-07
Est. Completion
2011-07

About This Study

The purpose of this study is to see if daily massage therapy will help premature infants respond to stress better, as well as improve their growth and neurobehavioral development.

Conditions Studied

Premature Birth of Newborn

Interventions

  • Developmental Massage Therapy
  • no intervention

Eligibility

Age:N/A - 14 Days
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Premature infants born between 29 4/7 and 32 3/7 weeks gestation by physical exam at birth, and with birth weight, length and head circumference between the 5th and 95th percentiles for gestational age.

Exclusion Criteria:

* Intrauterine growth less than the 5th or greater than the 95th percentiles for gestational age, congenital anomalies, complex cardiac defects, severe CNS injury, hypothyroidism, inborn errors of metabolism, or inability to establish full enteral feeds by day of life 14.

Study Locations (3)

Intermountain Medical Center
Murray, Utah, United States
St. Mark's Hospital
Salt Lake City, Utah, United States
University of Utah
Salt Lake City, Utah, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study | Huxley